Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
about
EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal TelangiectasiaMacular telangiectasia type 2.Long-term course in type 2 idiopathic macular telangiectasia.SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF NEOVASCULAR MACULAR TELANGIECTASIA TYPE 2.Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature.Intravitreal anti-VEGF treatment for subretinal neovascularisation secondary to type 2 idiopathic juxtafoveolar telangiectasia.Anti-Vascular Endothelial Growth Factor Treatment for Proliferative Macular Telangiectasia Type 2Long term result of intravitreal bevacizumab in a patient newly transformed to proliferative macular telangiectasia type 2.Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia.CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
P2860
Q30490563-8C961216-C4DE-430B-A180-08552245BE3FQ33790472-60B103E2-C789-42E2-ABCB-A0A69B6FD698Q34316044-10ADDBD3-0D20-4B01-9DCF-C4209E2D871AQ34686509-C1FEE37F-0346-4962-B004-2D80FDF01E91Q35803256-370EBC70-80CE-48CD-88E6-BA0AAED2F3E8Q35989542-EBAA73ED-29AB-4F02-A6B2-1DEE04434083Q36256224-E0972913-666E-4F57-89E1-B0CA7CF1E3D9Q36837306-F7C64166-78D0-48DA-80E2-E9086A1B4DDDQ37346421-045B14BE-3C50-413D-8C43-CCD56483FE45Q37525817-0F7A5C2B-0DC7-4B56-B51D-3137643A9BECQ50088688-D2E0A6A8-1F0C-47CC-84C6-8BB8EF54261B
P2860
Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intravitreal bevacizumab for t ...... pathic macular telangiectasia.
@en
Intravitreal bevacizumab for t ...... pathic macular telangiectasia.
@nl
type
label
Intravitreal bevacizumab for t ...... pathic macular telangiectasia.
@en
Intravitreal bevacizumab for t ...... pathic macular telangiectasia.
@nl
prefLabel
Intravitreal bevacizumab for t ...... pathic macular telangiectasia.
@en
Intravitreal bevacizumab for t ...... pathic macular telangiectasia.
@nl
P2093
P50
P1433
P1476
Intravitreal bevacizumab for t ...... opathic macular telangiectasia
@en
P2093
A Brock Roller
Narendra M Patel
Vinit B Mahajan
P304
P356
10.1097/IAE.0B013E31820D3FEB
P577
2011-10-01T00:00:00Z